Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

Fisetin inhibits human melanoma cell invasion through promotion of mesenchymal to epithelial transition and by targeting MAPK and NFκB signaling pathways.

Pal HC, Sharma S, Strickland LR, Katiyar SK, Ballestas ME, Athar M, Elmets CA, Afaq F.

PLoS One. 2014 Jan 23;9(1):e86338. doi: 10.1371/journal.pone.0086338. eCollection 2014.

PMID:
24466036
[PubMed - in process]
Free PMC Article
2.

Integrative genomics identifies gene signature associated with melanoma ulceration.

Rakosy Z, Ecsedi S, Toth R, Vizkeleti L, Hernandez-Vargas H, Lazar V, Emri G, Szatmari I, Herceg Z, Adany R, Balazs M.

PLoS One. 2013;8(1):e54958. doi: 10.1371/journal.pone.0054958. Epub 2013 Jan 30. Erratum in: PLoS One. 2013;8(4). doi:10.1371/annotation/27b2c2c3-3b09-4c0c-9e20-8dc0226404f3. Herandez-Vargas, Hector [corrected to Hernandez-Vargas, Hector].

PMID:
23383013
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes.

Pedersen M, Küsters-Vandevelde HV, Viros A, Groenen PJ, Sanchez-Laorden B, Gilhuis JH, van Engen-van Grunsven IA, Renier W, Schieving J, Niculescu-Duvaz I, Springer CJ, Küsters B, Wesseling P, Blokx WA, Marais R.

Cancer Discov. 2013 Apr;3(4):458-69. doi: 10.1158/2159-8290.CD-12-0464. Epub 2013 Jan 9.

PMID:
23303902
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.

Boyd SC, Mijatov B, Pupo GM, Tran SL, Gowrishankar K, Shaw HM, Goding CR, Scolyer RA, Mann GJ, Kefford RF, Rizos H, Becker TM.

J Invest Dermatol. 2013 May;133(5):1269-77. doi: 10.1038/jid.2012.421. Epub 2012 Nov 29.

PMID:
23190890
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, Ariyan S, Narayan D, Dutton-Regester K, Capatana A, Holman EC, Bosenberg M, Sznol M, Kluger HM, Brash DE, Stern DF, Materin MA, Lo RS, Mane S, Ma S, Kidd KK, Hayward NK, Lifton RP, Schlessinger J, Boggon TJ, Halaban R.

Nat Genet. 2012 Sep;44(9):1006-14. doi: 10.1038/ng.2359. Epub 2012 Jul 29.

PMID:
22842228
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

RACK1, a clue to the diagnosis of cutaneous melanomas in horses.

Campagne C, Julé S, Bernex F, Estrada M, Aubin-Houzelstein G, Panthier JJ, Egidy G.

BMC Vet Res. 2012 Jun 29;8:95. doi: 10.1186/1746-6148-8-95.

PMID:
22747534
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Image and statistical analysis of melanocytic histology.

Miedema J, Marron JS, Niethammer M, Borland D, Woosley J, Coposky J, Wei S, Reisner H, Thomas NE.

Histopathology. 2012 Sep;61(3):436-44. doi: 10.1111/j.1365-2559.2012.04229.x. Epub 2012 Jun 11.

PMID:
22687043
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Molecular profiling reveals low- and high-grade forms of primary melanoma.

Harbst K, Staaf J, Lauss M, Karlsson A, Måsbäck A, Johansson I, Bendahl PO, Vallon-Christersson J, Törngren T, Ekedahl H, Geisler J, Höglund M, Ringnér M, Lundgren L, Jirström K, Olsson H, Ingvar C, Borg Å, Tsao H, Jönsson G.

Clin Cancer Res. 2012 Aug 1;18(15):4026-36. doi: 10.1158/1078-0432.CCR-12-0343. Epub 2012 Jun 6. Erratum in: Clin Cancer Res. 2012 Oct 15;18(20):5829. Höglund, Markus [corrected to Höglund, Mattias]; Ringnér, Mattias [corrected to Ringnér, Markus].

PMID:
22675174
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Biomarkers as key contributors in treating malignant melanoma metastases.

de Souza CF, Morais AS, Jasiulionis MG.

Dermatol Res Pract. 2012;2012:156068. doi: 10.1155/2012/156068. Epub 2011 Oct 31.

PMID:
22110486
[PubMed]
Free PMC Article
10.

Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Greenwald HS, Friedman EB, Osman I.

Melanoma Res. 2012 Feb;22(1):1-8. doi: 10.1097/CMR.0b013e32834e6aa0. Review.

PMID:
22108608
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Prognostic parameters for the primary care of melanoma patients: what is really risky in melanoma?

Göppner D, Leverkus M.

J Skin Cancer. 2011;2011:521947. doi: 10.1155/2011/521947. Epub 2011 Oct 11.

PMID:
22007305
[PubMed]
Free PMC Article
12.

Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.

Kvaskoff M, Whiteman DC, Zhao ZZ, Montgomery GW, Martin NG, Hayward NK, Duffy DL.

Twin Res Hum Genet. 2011 Oct;14(5):422-32. doi: 10.1375/twin.14.5.422.

PMID:
21962134
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf.

Taylor KL, Lister JA, Zeng Z, Ishizaki H, Anderson C, Kelsh RN, Jackson IJ, Patton EE.

Development. 2011 Aug;138(16):3579-89. doi: 10.1242/dev.064014. Epub 2011 Jul 19.

PMID:
21771814
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin.

Whiteman DC, Pavan WJ, Bastian BC.

Pigment Cell Melanoma Res. 2011 Oct;24(5):879-97. doi: 10.1111/j.1755-148X.2011.00880.x. Epub 2011 Aug 16. Review.

PMID:
21707960
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Parsing out the complexity of RAF inhibitor resistance.

McMahon M.

Pigment Cell Melanoma Res. 2011 Apr;24(2):361-5. doi: 10.1111/j.1755-148X.2010.00824.x. Epub 2011 Jan 12. No abstract available.

PMID:
21392366
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk